|
1
|
Williams AR and Hare JM: Mesenchymal stem
cells: Biology, pathophysiology, translational findings, and
therapeutic implications for cardiac disease. Circ Res.
109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oswald J, Boxberger S, Jørgensen B,
Feldmann S, Ehninger G, Bornhäuser M and Werner C: Mesenchymal stem
cells can be differentiated into endothelial cells in vitro. Stem
Cells. 22:377–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Silva GV, Litovsky S, Assad JA, Sousa AL,
Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, et al:
Mesenchymal stem cells differentiate into an endothelial phenotype,
enhance vascular density, and improve heart function in a canine
chronic ischemia model. Circulation. 111:150–156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suzuki S, Narita Y, Yamawaki A, Murase Y,
Satake M, Mutsuga M, Okamoto H, Kagami H, Ueda M and Ueda Y:
Effects of extracellular matrix on differentiation of human bone
marrow-derived mesenchymal stem cells into smooth muscle cell
lineage: Utility for cardiovascular tissue engineering. Cells
Tissues Organs. 191:269–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang Z, Wang A, Yuan F, Yan Z, Liu B, Chu
JS, Helms JA and Li S: Differentiation of multipotent vascular stem
cells contributes to vascular diseases. Nat Commun. 3:8752012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Forte A, Finicelli M, Mattia M, Berrino L,
Rossi F, De Feo M, Cotrufo M, Cipollaro M, Cascino A and Galderisi
U: Mesenchymal stem cells effectively reduce surgically induced
stenosis in rat carotids. J Cell Physiol. 217:789–799. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forte A, Rinaldi B, Sodano L, Berrino L,
Rossi F, Finicelli M, Grossi M, Cobellis G, Botti C, De Feo M, et
al: Stem cell therapy for arterial restenosis: Potential parameters
contributing to the success of bone marrow-derived mesenchymal
stromal cells. Cardiovasc Drugs Ther. 26:9–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shoji M, Oskowitz A, Malone CD, Prockop DJ
and Pochampally R: Human mesenchymal stromal cells (MSCs) reduce
neointimal hyperplasia in a mouse model of flow-restriction by
transient suppression of anti-inflammatory cytokines. J Atheroscler
Thromb. 18:464–474. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng J, Liu JP, Miao L, He GX, Li D, Wang
HD and Jing T: Conditional expression of the type 2 angiotensin ii
receptor in mesenchymal stem cells inhibits neointimal formation
after arterial injury. J Cardiovasc Transl Res. 7:635–643. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang CH, Cherng WJ, Yang NI, Kuo LT, Hsu
CM, Yeh HI, Lan YJ, Yeh CH and Stanford WL: Late-outgrowth
endothelial cells attenuate intimal hyperplasia contributed by
mesenchymal stem cells after vascular injury. Arterioscler Thromb
Vasc Biol. 28:54–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liao J, Chen X, Li Y, Ge Z, Duan H, Zou Y
and Ge J: Transfer of bone-marrow-derived mesenchymal stem cells
influences vascular remodeling and calcification after balloon
injury in hyperlipidemic rats. J Biomed Biotechnol.
2012:1652962012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang FB, Li L, Fang B, Zhu DL, Yang HT
and Gao PJ: Passage-restricted differentiation potential of
mesenchymal stem cells into cardiomyocyte-like cells. Biochem
Biophys Res Commun. 336:784–792. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim S, Kawamura M, Wanibuchi H, Ohta K,
Hamaguchi A, Omura T, Yukimura T, Miura K and Iwao H: Angiotensin
II type 1 receptor blockade inhibits the expression of
immediate-early genes and fibronectin in rat injured artery.
Circulation. 92:88–95. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pankajakshan D, Kansal V and Agrawal DK:
In vitro differentiation of bone marrow derived porcine mesenchymal
stem cells to endothelial cells. J Tissue Eng Regen Med. 7:911–920.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gan LM, Grönros J, Hägg U, Wikström J,
Theodoropoulos C, Friberg P and Fritsche-Danielson R: Non-invasive
real-time imaging of atherosclerosis in mice using ultrasound
biomicroscopy. Atherosclerosis. 190:313–320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu DJ, Xu JZ, Wu YJ, Jean-Charles L, Xiao
B, Gao PJ and Zhu DL: Effects of fasudil on early atherosclerotic
plaque formation and established lesion progression in
apolipoprotein E-knockout mice. Atherosclerosis. 207:68–73. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hillebrands JL, Klatter FA, van den Hurk
BM, Popa ER, Nieuwenhuis P and Rozing J: Origin of neointimal
endothelium and alpha-actin-positive smooth muscle cells in
transplant arteriosclerosis. J Clin Invest. 107:1411–1422. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grimm PC, Nickerson P, Jeffery J, Savani
RC, Gough J, McKenna RM, Stern E and Rush DN: Neointimal and
tubulointerstitial infiltration by recipient mesenchymal cells in
chronic renal-allograft rejection. N Engl J Med. 345:93–97. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li M, Li S, Yu L, Wu J, She T, Gan Y, Hu
Z, Liao W and Xia H: Bone mesenchymal stem cells contributed to the
neointimal formation after arterial injury. PLoS One. 8:e827432013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yue WM, Liu W, Bi YW, He XP, Sun WY, Pang
XY, Gu XH and Wang XP: Mesenchymal stem cells differentiate into an
endothelial phenotype, reduce neointimal formation, and enhance
endothelial function in a rat vein grafting model. Stem Cells Dev.
17:785–793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kerkelä E, Hakkarainen T, Mäkelä T, Raki
M, Kambur O, Kilpinen L, Nikkilä J, Lehtonen S, Ritamo I, Pernu R,
et al: Transient proteolytic modification of mesenchymal stromal
cells increases lung clearance rate and targeting to injured
tissue. Stem Cells Transl Med. 2:510–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Psaltis PJ, Puranik AS, Spoon DB, Chue CD,
Hoffman SJ, Witt TA, Delacroix S, Kleppe LS, Mueske CS, Pan S, et
al: Characterization of a resident population of adventitial
macrophage progenitor cells in postnatal vasculature. Circ Res.
115:364–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Wong MM, Campagnolo P, Simpson R,
Winkler B, Margariti A, Hu Y and Xu Q: Adventitial stem cells in
vein grafts display multilineage potential that contributes to
neointimal formation. Arterioscler Thromb Vasc Biol. 33:1844–1851.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grudzinska MK, Kurzejamska E, Bojakowski
K, Soin J, Lehmann MH, Reinecke H, Murry CE, Soderberg-Naucler C
and Religa P: Monocyte chemoattractant protein 1-mediated migration
of mesenchymal stem cells is a source of intimal hyperplasia.
Arterioscler Thromb Vasc Biol. 33:1271–1279. 2013. View Article : Google Scholar : PubMed/NCBI
|
